Our company’s R&D! The first domestic reorganized subunit New Crown Vaccine approved entered clinical trial

This is the first approved clinical recombinant subunit new crown vaccine to enter the clinical trial in China, and it is also the only approved in our province >The new crown vaccine that entered the clinical trial. January 29,…